“…In sharp contrast, catalyzed C-H activation has recently emerged as a complementary strategy for step-economical late-stage modifications. [12][13][14][15][16][17][18] C-H activation has, thus, been recognized as an enabling tool for late-stage peptide functionalizations, [19][20][21][22] with major contributions by Albericio and co-workers, 23 Lavilla and co-workers, 24 Shi and co-workers, 25 Wang and co-workers, 26 Yu and co-workers, 27,28 and Ackermann and co-workers [29][30][31][32][33][34][35][36][37] In this context, the functionalization of tryptophan-containing peptides has attracted considerable interest, due to tryptophan's low natural abundance as well as its unique impact on biological events. 38 However, all tryptophan C-H activations are severely limited to the activated C2 position (Figure 1B), which is in sharp contrast to the predominance of C7-substituted indoles/tryptophans in numerous bioactive agents and important structurally complex peptide-natural products (Figure 1A).…”